Somatic BRCA mutations which are present only in the tumor cells, have been reported to be up to 15–30% of all BRCA1/2 mutations, and can be found in various malignancies, such as 3% of breast cancer cases, and over 12% of advanced prostate cancer patients [6–10]. This evidence concerns the gene BRCA1 and breast cancer.